Arianne Theiss
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 15 | 2020 | 437 | 3.850 |
Why?
| | Colitis | 12 | 2025 | 280 | 3.750 |
Why?
| | Mitochondria | 13 | 2025 | 984 | 3.490 |
Why?
| | Inflammatory Bowel Diseases | 13 | 2025 | 365 | 3.190 |
Why?
| | Intestinal Mucosa | 21 | 2026 | 676 | 2.990 |
Why?
| | Paneth Cells | 5 | 2026 | 20 | 2.700 |
Why?
| | Crohn Disease | 5 | 2023 | 260 | 1.850 |
Why?
| | Extracellular Vesicles | 3 | 2025 | 171 | 1.680 |
Why?
| | Colon | 11 | 2025 | 304 | 1.680 |
Why?
| | Colorectal Neoplasms | 5 | 2025 | 845 | 1.640 |
Why?
| | Carcinogenesis | 3 | 2025 | 229 | 1.570 |
Why?
| | STAT3 Transcription Factor | 6 | 2015 | 207 | 1.440 |
Why?
| | Ileitis | 2 | 2023 | 33 | 1.400 |
Why?
| | Benzofurans | 2 | 2020 | 26 | 1.110 |
Why?
| | Colonic Neoplasms | 5 | 2025 | 259 | 1.070 |
Why?
| | Gastrointestinal Microbiome | 4 | 2024 | 771 | 0.990 |
Why?
| | Caco-2 Cells | 12 | 2018 | 79 | 0.950 |
Why?
| | Inflammation | 11 | 2023 | 2878 | 0.930 |
Why?
| | Gastrointestinal Diseases | 2 | 2025 | 216 | 0.900 |
Why?
| | Intestines | 6 | 2023 | 358 | 0.870 |
Why?
| | Intra-Abdominal Fat | 1 | 2025 | 100 | 0.870 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2021 | 1455 | 0.860 |
Why?
| | Epithelial Cells | 7 | 2025 | 1125 | 0.850 |
Why?
| | Obesity | 3 | 2025 | 3077 | 0.830 |
Why?
| | Axin Protein | 2 | 2020 | 19 | 0.810 |
Why?
| | Mice | 30 | 2025 | 18339 | 0.770 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2021 | 1217 | 0.760 |
Why?
| | Mitochondrial Membranes | 1 | 2023 | 40 | 0.750 |
Why?
| | Inflammasomes | 2 | 2021 | 146 | 0.750 |
Why?
| | beta Catenin | 2 | 2025 | 252 | 0.750 |
Why?
| | Antioxidants | 2 | 2021 | 549 | 0.750 |
Why?
| | Autophagy | 4 | 2023 | 286 | 0.720 |
Why?
| | Fatty Acids | 1 | 2025 | 450 | 0.710 |
Why?
| | Apoptosis | 6 | 2020 | 2430 | 0.680 |
Why?
| | Animals | 36 | 2026 | 38058 | 0.670 |
Why?
| | Cytokines | 4 | 2026 | 2061 | 0.660 |
Why?
| | Intestinal Neoplasms | 1 | 2020 | 30 | 0.650 |
Why?
| | Stem Cells | 1 | 2025 | 626 | 0.640 |
Why?
| | Adipose Tissue | 1 | 2025 | 652 | 0.640 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5992 | 0.620 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 169 | 0.610 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.610 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 210 | 0.550 |
Why?
| | Glutarates | 1 | 2018 | 11 | 0.550 |
Why?
| | Cell Nucleus | 1 | 2020 | 618 | 0.520 |
Why?
| | Signal Transduction | 5 | 2026 | 5226 | 0.500 |
Why?
| | Interleukin-17 | 4 | 2022 | 118 | 0.490 |
Why?
| | Mice, Knockout | 9 | 2025 | 3121 | 0.470 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2025 | 46 | 0.450 |
Why?
| | Dextran Sulfate | 5 | 2018 | 92 | 0.450 |
Why?
| | Colitis, Ulcerative | 4 | 2021 | 147 | 0.440 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2015 | 529 | 0.430 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2023 | 192 | 0.420 |
Why?
| | Oxidative Stress | 4 | 2025 | 1339 | 0.420 |
Why?
| | Humans | 41 | 2026 | 144759 | 0.410 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2022 | 14 | 0.410 |
Why?
| | Reactive Oxygen Species | 4 | 2023 | 621 | 0.400 |
Why?
| | NF-E2 Transcription Factor, p45 Subunit | 1 | 2013 | 3 | 0.390 |
Why?
| | Biological Products | 1 | 2016 | 252 | 0.370 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 432 | 0.350 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4557 | 0.340 |
Why?
| | Mice, Transgenic | 6 | 2020 | 2182 | 0.320 |
Why?
| | Homeostasis | 2 | 2026 | 640 | 0.320 |
Why?
| | Heme Oxygenase-1 | 2 | 2025 | 74 | 0.320 |
Why?
| | Immunity, Innate | 3 | 2026 | 846 | 0.310 |
Why?
| | alpha Karyopherins | 1 | 2009 | 11 | 0.310 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 85 | 0.290 |
Why?
| | Transcription Factors | 3 | 2025 | 1741 | 0.290 |
Why?
| | Stress, Physiological | 1 | 2012 | 453 | 0.280 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2005 | 319 | 0.280 |
Why?
| | Interleukin-6 | 3 | 2007 | 780 | 0.270 |
Why?
| | DNA-Binding Proteins | 2 | 2025 | 1499 | 0.270 |
Why?
| | Biopsy | 3 | 2021 | 1075 | 0.260 |
Why?
| | Nanoparticles | 2 | 2011 | 519 | 0.260 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 380 | 0.250 |
Why?
| | Collagen | 2 | 2005 | 456 | 0.240 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 28 | 0.230 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 41 | 0.230 |
Why?
| | Growth Hormone | 1 | 2005 | 92 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 138 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 175 | 0.220 |
Why?
| | Antineoplastic Agents | 2 | 2014 | 2194 | 0.220 |
Why?
| | Human Growth Hormone | 1 | 2004 | 46 | 0.210 |
Why?
| | Cell Proliferation | 3 | 2020 | 2496 | 0.210 |
Why?
| | Glycolysis | 1 | 2025 | 339 | 0.200 |
Why?
| | Diet, High-Fat | 1 | 2025 | 261 | 0.200 |
Why?
| | Iron | 1 | 2025 | 359 | 0.190 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2608 | 0.190 |
Why?
| | Fibroblasts | 2 | 2005 | 1034 | 0.190 |
Why?
| | Butyrates | 1 | 2023 | 67 | 0.190 |
Why?
| | p21-Activated Kinases | 1 | 2022 | 14 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 208 | 0.180 |
Why?
| | Male | 12 | 2025 | 72315 | 0.180 |
Why?
| | Up-Regulation | 2 | 2021 | 851 | 0.180 |
Why?
| | Cell Survival | 2 | 2018 | 1098 | 0.180 |
Why?
| | Enterocytes | 1 | 2021 | 16 | 0.170 |
Why?
| | RNA, Small Interfering | 3 | 2017 | 635 | 0.170 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1087 | 0.170 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2021 | 17 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 13 | 0.170 |
Why?
| | Genes, Reporter | 2 | 2013 | 275 | 0.160 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2020 | 3 | 0.160 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 262 | 0.160 |
Why?
| | Gene Silencing | 2 | 2012 | 205 | 0.160 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 339 | 0.160 |
Why?
| | Enterocolitis | 1 | 2020 | 18 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 314 | 0.160 |
Why?
| | Membrane Proteins | 2 | 2025 | 1166 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 919 | 0.150 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 85 | 0.150 |
Why?
| | Interleukin-18 | 1 | 2020 | 235 | 0.140 |
Why?
| | Organoids | 1 | 2020 | 141 | 0.140 |
Why?
| | Piperidines | 1 | 2020 | 217 | 0.140 |
Why?
| | Azoxymethane | 1 | 2018 | 17 | 0.140 |
Why?
| | Immunity, Mucosal | 1 | 2019 | 98 | 0.140 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 377 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 427 | 0.130 |
Why?
| | Intercellular Adhesion Molecule-3 | 1 | 2017 | 2 | 0.130 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3540 | 0.130 |
Why?
| | Lipid Metabolism | 1 | 2021 | 527 | 0.130 |
Why?
| | LIM Domain Proteins | 1 | 2017 | 21 | 0.130 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 40 | 0.130 |
Why?
| | Curcuma | 1 | 2017 | 1 | 0.130 |
Why?
| | Oils, Volatile | 1 | 2017 | 6 | 0.130 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 49 | 0.130 |
Why?
| | Blotting, Western | 2 | 2013 | 1187 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 2 | 2010 | 675 | 0.130 |
Why?
| | Female | 9 | 2025 | 78271 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2017 | 2832 | 0.120 |
Why?
| | Green Fluorescent Proteins | 2 | 2010 | 405 | 0.120 |
Why?
| | Fibrosis | 3 | 2017 | 548 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2583 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 1257 | 0.120 |
Why?
| | Glutathione | 2 | 2009 | 375 | 0.120 |
Why?
| | Myofibroblasts | 1 | 2017 | 143 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 297 | 0.120 |
Why?
| | Ubiquitination | 3 | 2022 | 118 | 0.110 |
Why?
| | DNA Methylation | 1 | 2021 | 681 | 0.110 |
Why?
| | Oncogene Protein p21(ras) | 1 | 2015 | 15 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2014 | 4154 | 0.110 |
Why?
| | Biological Assay | 1 | 2016 | 128 | 0.110 |
Why?
| | Neoplasms | 1 | 2011 | 2875 | 0.110 |
Why?
| | Risk | 1 | 2018 | 911 | 0.110 |
Why?
| | Phosphorylation | 2 | 2022 | 1732 | 0.110 |
Why?
| | Gene Knockdown Techniques | 2 | 2015 | 336 | 0.110 |
Why?
| | NF-kappa B | 2 | 2010 | 661 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 459 | 0.100 |
Why?
| | Interleukin-10 | 2 | 2006 | 309 | 0.100 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 5 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2017 | 474 | 0.100 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 34 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1199 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 965 | 0.100 |
Why?
| | RNA | 2 | 2013 | 940 | 0.100 |
Why?
| | Luciferases | 1 | 2013 | 152 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2016 | 509 | 0.090 |
Why?
| | Phenotype | 1 | 2021 | 3162 | 0.090 |
Why?
| | Barrett Esophagus | 1 | 2015 | 165 | 0.090 |
Why?
| | Peroxidase | 1 | 2013 | 168 | 0.090 |
Why?
| | Protein Binding | 2 | 2020 | 2273 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.090 |
Why?
| | HCT116 Cells | 1 | 2012 | 78 | 0.090 |
Why?
| | Free Radical Scavengers | 1 | 2012 | 82 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2012 | 75 | 0.090 |
Why?
| | Intracellular Space | 1 | 2012 | 66 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2012 | 139 | 0.080 |
Why?
| | Polyethyleneimine | 1 | 2011 | 18 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 310 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1313 | 0.080 |
Why?
| | DNA | 2 | 2009 | 1463 | 0.080 |
Why?
| | Time Factors | 4 | 2017 | 7173 | 0.080 |
Why?
| | Th17 Cells | 2 | 2021 | 101 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 299 | 0.080 |
Why?
| | Disease Progression | 1 | 2018 | 2847 | 0.080 |
Why?
| | Adenocarcinoma | 2 | 2009 | 928 | 0.070 |
Why?
| | Protein Carbonylation | 1 | 2009 | 57 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 121 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2009 | 95 | 0.070 |
Why?
| | Gene Expression | 2 | 2020 | 1490 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 441 | 0.070 |
Why?
| | Acute Disease | 1 | 2010 | 1030 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2882 | 0.060 |
Why?
| | Salmonella typhimurium | 1 | 2009 | 190 | 0.060 |
Why?
| | Keratin-8 | 1 | 2007 | 4 | 0.060 |
Why?
| | Transcription Initiation Site | 1 | 2007 | 43 | 0.060 |
Why?
| | Transfection | 1 | 2009 | 940 | 0.060 |
Why?
| | Response Elements | 1 | 2007 | 89 | 0.060 |
Why?
| | Glutathione Transferase | 1 | 2006 | 100 | 0.060 |
Why?
| | Keratins | 1 | 2007 | 172 | 0.060 |
Why?
| | Prognosis | 1 | 2014 | 4282 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 11 | 0.060 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 56 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2005 | 58 | 0.060 |
Why?
| | Cecum | 1 | 2005 | 37 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2005 | 204 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 20 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2005 | 103 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 160 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2005 | 79 | 0.060 |
Why?
| | Heme | 1 | 2025 | 89 | 0.060 |
Why?
| | Homozygote | 1 | 2005 | 199 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2006 | 336 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2005 | 163 | 0.050 |
Why?
| | Polysaccharides | 1 | 2005 | 87 | 0.050 |
Why?
| | Granuloma | 1 | 2005 | 96 | 0.050 |
Why?
| | Joints | 1 | 2005 | 107 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2005 | 402 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2005 | 766 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 383 | 0.050 |
Why?
| | Drug Interactions | 1 | 2004 | 398 | 0.050 |
Why?
| | Models, Biological | 1 | 2011 | 1821 | 0.050 |
Why?
| | Perylene | 1 | 2002 | 10 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2155 | 0.050 |
Why?
| | Escherichia coli | 1 | 2007 | 854 | 0.050 |
Why?
| | Photochemotherapy | 1 | 2002 | 39 | 0.050 |
Why?
| | Photosensitizing Agents | 1 | 2002 | 42 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2930 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2027 | 0.040 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 38 | 0.040 |
Why?
| | Citrobacter rodentium | 1 | 2020 | 6 | 0.040 |
Why?
| | Genotype | 1 | 2005 | 1833 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2021 | 251 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 2020 | 41 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 154 | 0.040 |
Why?
| | Chronic Disease | 1 | 2005 | 1813 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1496 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 477 | 0.040 |
Why?
| | Esophageal Neoplasms | 1 | 2002 | 347 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 348 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 558 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 641 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 784 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2925 | 0.030 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 337 | 0.030 |
Why?
| | Curcumin | 1 | 2017 | 25 | 0.030 |
Why?
| | Permeability | 2 | 2007 | 168 | 0.030 |
Why?
| | Rats | 1 | 2005 | 5597 | 0.030 |
Why?
| | Collagen Type I | 1 | 2017 | 147 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 732 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 202 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 140 | 0.030 |
Why?
| | Actins | 1 | 2017 | 425 | 0.030 |
Why?
| | Colonoscopy | 1 | 2017 | 261 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 744 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 917 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1782 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 2050 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1025 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 354 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5408 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 4089 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 321 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 329 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8265 | 0.010 |
Why?
| | Aminolevulinic Acid | 1 | 2002 | 4 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1511 | 0.010 |
Why?
| | Anthracenes | 1 | 2002 | 31 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2002 | 140 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2007 | 3604 | 0.010 |
Why?
| | Middle Aged | 2 | 2017 | 35875 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17066 | 0.010 |
Why?
| | Aged | 1 | 2017 | 25913 | 0.010 |
Why?
| | Adult | 1 | 2017 | 40449 | 0.010 |
Why?
|
|
Theiss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|